Ammar Arsiwala, Ph.D.
Director, Antibody Development, Ginkgo Bioworks, Inc
Dr. Ammar Arsiwala currently leads the Antibody Developability team at Gingko Bioworks, overseeing the development of methods and workflows for high-throughput (HT) antibody production and biophysical assay characterization to support antibody AI/ML modeling and drug discovery. Dr. Arsiwala earned his PhD from Georgia Institute of Technology, with a focus on the design of broadly protective vaccines for infectious diseases and previously worked at Amgen Inc. in late-stage antibody process development.
